Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways

Apoptosis

Volumn 20, Issue 2, 2015, Pages 196-209

  Narayanan, Kannan Badri ^a   Park, Hyun Ho ^a  

^a Yeungnam University   (South Korea)

Author keywords

Apoptosis; Inflammation; Interleukin 1 receptors; TIR domain; Toll like receptors

Indexed keywords

ADAPTOR PROTEIN; INTERLEUKIN 1 RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; STERILE ALPHA AND HEAT ARMADILLO MOTIF CONTAINING PROTEIN; TOLL INTERLEUKIN 1 RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; UNCLASSIFIED DRUG; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

APOPTOSIS; ARTICLE; IMMUNOCOMPETENT CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; INNATE IMMUNITY; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; HUMANS; IMMUNITY, INNATE; MODELS, MOLECULAR; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84925486323     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-014-1073-1     Document Type: Article

References (111)

1. Bonardi V, Cherkis K, Nishimura MT, Dangl JL (2012) A new eye on NLR proteins: focused on clarity or diffused by complexity? Curr Opin Immunol 24(1):41-50
2. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373-384
3. Eisenacher K, Krug A (2012) Regulation of RLR-mediated innate immune signaling - it is all about keeping the balance. Eur J Cell Biol 91(1):36-47
4. Kingeter LM, Lin X (2012) C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses. Cell Mol Immunol 9(2):105-112
5. Werts C, Girardin SE, Philpott DJ (2006) TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell Death Diff 13(5):798-815
6. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216
7. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol 2(8):675-680
8. Akira S, Takeda K (2004) Toll-like receptors signalling. Nat Rev Immunol 4(7):499-511
9. Rakoff-Nahoum S, Medzhitov R (2009) Toll-like receptors and cancer. Nat Rev Cancer 9(1):57-63
10. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86(6):973-983
11. Williams MJ, Rodriguez A, Kimbrell DA, Eldon ED (1997) The 18-wheeler mutation reveals complex anti-bacterial gene regulation in Drosophila host defense. EMBO J 16(20):6120-6130
12. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homo-logue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397
13. Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21(4):317-337
14. Beutler BA (2009) TLRs and innate immunity. Blood 113(7):1399-1407
15. Jin MS, Lee JO (2008) Structures of the Toll-like receptor family and its ligand complexes. Immunity 29(2):182-191
16. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5(10):987-995
17. Dai J, Liu B, Li Z (2009) Regulatory T cells and Toll-like receptors: what is the missing link? Int Immunopharmacol 9(5):528-533
18. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783-801
19. Miyake K (2007) Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 19(1):3-10
20. Kumar H, Kawai T, Akira S (2009) Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388(4):621-625
21. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL (2008) UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452(7184):234-238
22. Bowie A, O'Neill LAJ (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 67(4):508-514
23. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270(23):13757-13765
24. Gay N, Keith F (1991) Drosophila Toll and IL-1 receptor. Nature 351(6325):355-356
25. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550
26. Subramaniam S, Stansberg C, Cunningham C (2004) The interleukin 1 receptor family. Dev Comp Immunol 28(5):415-428
27. Heguy A, Baldari CT, Macchia G, Telford JL, Melli M (1992) Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the drosophila Toll protein are essential for IL-1R signal transduction. J Biol Chem 267(4):2605-2609
28. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479-490
29. Boraschi D, Tagliabue A (2006) The interleukin-1 receptor family. Vitam Horm 74:229-254
30. Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J (2003) Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 197(2):263-268
31. Lord KA, Hoffman-Liebermann B, Liebermann DA (1990) Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5(7):1095-1097
32. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11(1):115-122
33. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S (2000) Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 12(1):113-117
34. Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H (2000) Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 192(4):595-600
35. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor-5. Nature 410(6832):1099-1103
36. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo S, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S (2002) Small antiviral compounds activate immune cells via TLR7 MyD88-dependent signaling pathway. Nat Immunol 3(2):196-200
37. Horng T, Barton GM, Medzhitov R (2001) TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2(9):835-841
38. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S (2002) Essential role of TIRAP/Mal for activation of the signaling cascade shared by TLR2 and TLR4. Nature 420(6913):324-329
39. Horng T, Barton GM, Flavell RA, Medzhitov R (2002) The adaptor molecule TIRAP provides signaling specificity for Toll-like receptors. Nature 420(6913):329-333
40. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S (2003) Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301(5633):640-643
41. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B (2003) Identification of Lps2 as a key transducer of MyD88-independnet TIR signaling. Nature 424(6950):743-748
42. Bin LH, Xu LG, Shu HB (2003) TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling. J Biol Chem 278:24526-245312
43. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S (2003) TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4(11):1144-1150
44. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT (2003) LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF. J Exp Med 198(7):1043-1055
45. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T (2003) TIR-containing adapter molecule (TICAM)-2: a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β. J Biol Chem 278(50):49751-49762
46. Mink M, Fogelgren B, Olszewski K, Maroy P, Csiszar K (2001) A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/β-catenin that is conserved in mouse, Drosophila and C. elegans. Genomics 74:234-244
47. O'Neill LAJ, Fitzgerald KA, Bowie AG (2003) The Toll-IL-1 receptor adaptor family grows to five members. Trends in Immunol 24(6):286-289
48. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG (2006) The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 7(10):1074-1081
49. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond MS (2009) The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts west Nile virus pathogenesis. J Virol 83(18):9329-9338
50. Radons J, Gabler S, Wesche H, Korherr C, Hofmeister R, Falk W (2002) Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling. J Biol Chem 277(19):16456-16463
51. Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L (2000) Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408(6808):111-115
52. Nyman T, Stenmark P, Flodin S, Johansson I, Hammarstrom M, Nordlund PR (2008) The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem 283(18):11861-11865
53. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Marco FD, French L, Tschopp J (1998) MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273(20):12203-12209
54. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2(2):253-258
55. Khan JA, Brint EK, O'Neill LAJ, Tong L (2004) Crystal structure of the Toll/Interleukin-1 receptor domain of human IL-1RAPL. J Biol Chem 279:31664-31670
56. Ohnishi H, Tochio H, Kato Z, Orii KE, Li A, Kimura T, Hiroaki H, Kondo N, Shirakawa M (2009) Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc Natl Acad Sci USA 106(25):10260-10265
57. Valkov E, Stamp A, DiMaio F, Baker D, Verstak B, Roversi P, Kellie S, Sweet MJ, Mansell A, Gay NJ, Martin JL, Kobe B (2011) Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proc Natl Acad Sci USA 108(36):14879-14884
58. Jang TH, Park HH (2014) Crystal structure of TIR domain of TLR6 reveals novel dimeric interface of TIR-TIR interaction for Toll-like receptor signaling pathway. J Mol Biol. doi: 10.1016/j.jmb.2014.07.024
59. Zhou K, Kanai R, Lee P, Wang HW, Modis Y (2012) Toll-like receptor 5 forms asymmetric dimers in the absence of flagellin. J Struct Biol 177(2):402-409
60. Lin Z, Lu J, Zhou W, Shen Y (2012) Structural insignts into TIR domain specificity of the bridging adaptor Mal in TLR4 signaling. PLoS One 7(4):e34202
61. Loiarro M, Gallo G, Fanto N, Santis RD, Carminati P, Ruggiero V, Sette C (2009) Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases. J Biol Chem 284(41):28093-28103
62. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ (2000) Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103(2):351-361
63. Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L, Chen ZJ (2004) TAB 2 and TAB 3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol Cell 15(4):535-548
64. Carmody RJ, Chen YH (2007) Nuclear factor-κB: activation and regulation during Toll-like receptor signaling. Cell Mol Immunol 4(1):31-41
65. Yao J, Tae WK, Qin J, Jiang Z, Qian Y, Xiao H, Lu Y, Qian W, Gulen MF, Sizemore N, DiDonato J, Sato S, Akira S, Su B, Li X (2007) Interleukin-1 (IL-1)-induced TAK1-dependent versus MEKK3-dependent NF κB activation pathways bifurcate at IL-1 receptor-associated kinase modification. J Biol Chem 282(9):6075-6089
66. Sanz L, Diaz-Meco MT, Nakano H, Moscat J (2000) The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway. EMBO J 19(7):1576-1586
67. Karin M, Liu ZG, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9(2):240-246
68. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4(5):E131-E136
69. Kawai T, Akira S (2006) TLR signalling. Cell death Differ 13(5):816-825
70. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537-549
71. Kim JY, Beg AA, Haura EB (2013) Non-canonical IKKs, IKKε and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer. Expert Opin Ther Targets 17(10):1109-1112
72. Doyle SE, Vaidya SA, O'Connell R, Dadgostar H, Dempsey PW, Wu T, Rao G, Sun R, Haberland M, Modlin R, Cheng G (2002) IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17(3):251-263
73. Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S (2002) Differential involvement of IFN-β in Toll-like receptor-stimulated dendritic cell activation. Int Immunol 14(10):1225-1231
74. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN (2002) TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages. Nat Immunol 3(4):392-398
75. Kumar H, Takeuchi O, Akira S (2013) Toll-like receptors. In: Lennarz WJ, Lane MD (eds) Encyclopedia of biological chemistry, vol 2. Academic Press, New York, pp 396-401
76. Salaun B, Romero P, Lebecque S (2007) Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur J Immunol 37(12):3311-3318
77. Li Q, Verma IM (2002) NF-κB regulation in the immune system. Nat Rev Immunol 2(10):725-734
78. Schmidt C (2006) Immune system's Toll-like receptors have good opportunity for cancer treatment. J Natl Cancer Inst 98(9):574-575
79. O'Neill LAJ (2006) Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Disc 5(7):549-563
80. Li F, Thiele I, Jamshidi N, Palsson BO (2009) Identification of potential pathway mediation targets in Toll-like receptor signaling. PLoS Comp Biol 5(2):e1000292
81. Von Bernuth H, Picard C, Jin Z et al (2008) Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321(5889):691-696
82. Ku CL, von Bernuth H, Picard C et al (2007) Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 204(10):2407-2422
83. Marsh BJ, Stenzel-Poore MP (2008) Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases. Curr Opin Pharmacol 8(1):8-13
84. O'Neill LAJ, Bryant CE, Doyle SL (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 61(2):177-197
85. Pedras-Vasconcelos J, Puig M, Verthelyi D (2009) TLRs as therapeutic targets in CNS inflammation and infection. Front Biosci (Elite Ed) 1:476-487
86. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396):2085-2088
87. Li C, Zienkiewicz J, Hawiger J (2005) Interactive sites in the Myd88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1β signaling pathway. J Biol Chem 280:26152-26159
88. Toshchakov VV, Szmacinski H, Couture LA, Lakowicz JR, Vogel SN (2011) Targeting TLR4 signaling by TLR4 TIR-derived decoy peptides: identification of the TLR4 TIR dimerization interface. J Immunol 186(8):4819-4827
89. Loiarro M, Sette C, Gallo G, Ciacci A, Fanto N, Mastroianni D, Carminati P, Ruggiero V (2005) Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-κB. J Biol Chem 280(16):15809-15814
90. Liu Y, Yuan Y, Li Y, Zhang J, Xiao G, Vodovotz Y, Billiar TR, Wilson MA, Fan J (2009) Interacting neuro-endocrine, innate, and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock. J Immunol 182(1):572-580
91. Ahmad R, Sylvester J, Zafarullah M (2007) MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation. Cell Signal 19(12):2549-2557
92. Uto T, Wang X, Sato K, Haraguchi M, Akagi T, Akashi M, Baba M (2007) Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 178(5):2979-2986
93. Toshchakov VY, Fenton MJ, Vogel SN (2007) Cutting edge: differential inhibition of TLR signaling pathways by cell-permeable peptides representing BB loops of TLRs. J Immunol 178(5):2655-2660
94. Toshchakov VU, Basu S, Fenton MJ, Vogel SN (2005) Differential involvement of BB loops of Toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J Immunol 175(1):494-500
95. Bartfai T, Behrens MM, Gaidarova S, Pemberton J, Shivanyuk A, Rebek J Jr (2003) A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses. Proc Natl Acad Sci USA 100(13):7971-7976
96. Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C, Chen Q, Li C, Li J, Li Y (2009) The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury. Cardiovasc Res 84(3):442-451
97. Davis CN, Mann E, Behrens MM, Gaidarova S, Rebek M, Rebek J Jr, Bartfai T (2006) MyD88-dependent and -independent signaling by Il-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proc Natl Acad Sci USA 103(8):2953-2958
98. Fanto N, Gallo G, Ciacci A, Semproni M, Vignola D, Quaglia M, Bombardi V, Mastroianni D, Zibella MP, Basile G, Sassano M, Ruggiero V, De Santis R, Carminati P (2008) Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88. J Med Chem 51(5):1189-1202
99. Loiarro M, Capolunghi F, Fanto N, Gallo G, Campo S, Arseni B, Carsetti R, Carminati P, De Santis R, Ruggiero V, Sette C (2007) Pivotal advance: inhibition of Myd88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol 82(4):801-810
100. Travis S, Yap LM, Hawkey C, Warren B, Lazarov M, Fong T, Tesi RJ (2005) RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. Inflamm Bowel Dis 11(8):713-719
101. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4):239-257
102. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-545
103. Thorburn A (2004) Death receptor-induced cell killing. Cell Signal 16(2):139-144
104. Kaiser WJ, Offermann MK (2005) Apoptosis induced by the Toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 174(8):4942-4952
105. Fekonja O, Avbelj M, Jerala R (2012) Suppression of TLR signaling by targeting TIR domain-containing proteins. Curr Protein Pept Sci 13(8):776-788
106. Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A (2000) The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J 19(13):3325-3336
107. Colomar A, Marty V, Medina C, Combe C, Parnet P, Amedee T (2003) Maturation and release of interleukin-1β by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors. J Biol Chem 278(33):30732-30740
108. Barshes NR, Wyllie S, Goss JA (2005) Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 77(5):587-597
109. Sjoholm A (1998) Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus. Cell Death Differ 5(6):461-468
110. Rothwell N, Allan S, Toulmond S (1997) The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiolocial and therapeutic implications. J Clin Invest 100(11):2648-2652
111. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20(19):2390-2400